L Mjörnstedt1, J Konar, I Skarp, M Olausson, L Sandberg, G Tufvesson. Show Affiliations » 1. Department of Surgery (Transplant Unit), Sahlgrenska Hospital, Göteborg, Sweden.
Abstract
Mesh： See more » Drug Therapy, CombinationFollow-Up StudiesGraft Rejection/immunologyGraft Rejection/mortalityGraft Rejection/prevention & controlGraft Survival/drug effectsGraft Survival/immunologyHLA Antigens/immunologyHLA-A Antigens/immunologyHLA-B Antigens/immunologyHLA-DR Antigens/immunologyHistocompatibility TestingHumansImmunosuppressive Agents/administration & dosageIsoantibodies/analysisKidney Transplantation/immunologyKidney Transplantation/mortalityPostoperative Complications/immunologyPostoperative Complications/mortalityPostoperative Complications/prevention & controlReoperationRisk FactorsSurvival Rate
Substances： See more » HLA AntigensHLA-A AntigensHLA-B AntigensHLA-DR AntigensImmunosuppressive AgentsIsoantibodies
Year: 1992 PMID： 1465834
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066